[Neodymium YAG laser in clinical urology. Current status and clinical experiences].
Of all the lasers available for medical applications only the Neodymium-YAG laser has been retained with a clear indication for open and endoscopic tumor destruction in urology. This is due to the biophysical properties of this laser. The main indications for Neodymium-YAG laser application are benign and malignant tumors of the glans penis and the penis shaft as well as multiple small tumors distributed over the urethra and bladder mucosa. But tumors of the ureter and renal pelvis can also be destroyed endoscopically with the laser. The advantages of Neodymium-YAG laser application are: the great radicality of the contact-free tumor destruction coupled with closure of the blood and lymphatic vessels of the tumor, no hemorrhages, no anesthesia, only conscious sedation, and above all, short operation times that make the procedure suitable for use in outpatients.
D000328:Adult; D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000601:surgery; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003218:Condylomata Acuminata / Q000601:surgery; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000601:surgery; D010412:Penile Neoplasms / Q000601:surgery; D014516:Ureteral Neoplasms / Q000601:surgery; D014521:Urethra / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000601:surgery; D014565:Urogenital Neoplasms / Q000601:surgery*
D008937:Mitomycins
Der Neodym-YAG-Laser in der Urologie. Derzeitiger Stand der klinischen Erfahrungen.